Ecraprost is a prodrug of prostaglandin E1. References: Nehler MR, Brass EP, Anthony R, Dormandy J, Jiao J, McNamara TO, Hiatt WR; Circulase investigators. Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes. J Vasc Surg. 2007 May;45(5):953-60; discussion 960-1. Epub 2007 Mar 9. PubMed PMID: 17350216.

纯度：≥98%

CAS：136892-64-3